Actively Recruiting

Phase Not Applicable
Age: 7Years - 15Years
All Genders
NCT06448767

The Effect of a Multispecies Probiotics on Autism Symptoms in Children

Led by Medical University of Warsaw · Updated on 2026-01-08

110

Participants Needed

3

Research Sites

103 weeks

Total Duration

On this page

Sponsors

M

Medical University of Warsaw

Lead Sponsor

W

Winclove Probiotics B.V.

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this trial, the investigators aim to evaluate the impact of a multispecies probiotic consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200, on the severity of autism symptoms, quality of life, gastrointestinal symptoms, sleep disturbances, parental stress levels and urinary p-cresol concentrations in children with Autism Spectrum Disorder aged 7 to 15 years.

CONDITIONS

Official Title

The Effect of a Multispecies Probiotics on Autism Symptoms in Children

Who Can Participate

Age: 7Years - 15Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Autism Spectrum Disorder (ASD) according to DSM-5 or ICD-10
  • Children not taking any medication or on the same medication for at least 2 months
  • Willingness of patients or their caregivers to provide written informed consent
  • Commitment to use nutritional supplements for 3 months during the trial
  • Agreement to not start any special diet during the study
  • Ability to complete questionnaires at baseline and after 12 weeks
Not Eligible

You will not qualify if you...

  • Use of antibiotics (except topical) within 2 months before enrollment
  • Use of probiotics or synbiotics within 2 months before enrollment
  • History of intolerance or allergy to probiotics, synbiotics, or any study product components
  • History of bowel surgery with resection or diagnosis of short bowel syndrome
  • Severe immunodeficiency in the child

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Department of Paediatrics, The Medical University of Warsaw

Warsaw, Warsaw, Poland, 02-091

Actively Recruiting

2

Department of Paediatrics, The Medical University of Warsaw

Warsaw, Warsaw, Poland, 02-091

Actively Recruiting

3

Department of Paediatrics, The Medical University of Warsaw

Warsaw, Warsaw, Poland, 02-091

Actively Recruiting

Loading map...

Research Team

M

Maja Kotowska, MD

CONTACT

J

Jan Łukasik, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here